Edition:
India

Lippo China Resources Ltd (0156.HK)

0156.HK on Hong Kong Stock

0.14HKD
10 Jul 2020
Change (% chg)

HK$-0.00 (-2.88%)
Prev Close
HK$0.14
Open
HK$0.14
Day's High
HK$0.14
Day's Low
HK$0.13
Volume
1,962,000
Avg. Vol
1,105,211
52-wk High
HK$0.19
52-wk Low
HK$0.12

Summary

Name Age Since Current Position

Tjondro Riady

59 2011 Executive Chairman of the Board

Luen wai Lee

70 2011 Chief Executive Officer, Executive Director

Siu Lung Lee

49 2015 Executive Director

Yuen Fun Luk

1992 Company Secretary

Nim Leung Chan

63 2004 Non-Executive Director

Edwin Neo

69 2002 Independent Non-Executive Director

King Fai Tsui

70 2004 Independent Non-Executive Director

Ha Kuk Yung

65 2004 Independent Non-Executive Director

Biographies

Name Description

Tjondro Riady

Dr. Tjondro Riady Ph.D. serves as Executive Chairman of the Board of the Company. Dr. Riady is also an executive director and the Chairman of the board of directors of Lippo Limited (“Lippo”) and Hongkong Chinese Limited (“HKC”), both are public listed companies in Hong Kong. He has been the Executive President of each of the Company, Lippo and HKC since January 2015. He is a member of the Remuneration Committee and Nomination Committee of each of the Company, Lippo and HKC. Dr. Riady also holds directorship in certain subsidiaries of the Company, Lippo and HKC. He is the Executive Chairman of OUE Limited, a company listed on the Mainboard of Singapore Exchange Securities Trading Limited (the “SGX-ST”). He is a non-executive non-independent director of Healthway Medical Corporation Limited (“HMC”), a company listed on the sponsor-supervised listing platform (the “Catalist Board”) of the SGX-ST. He is also an executive director of Auric Pacific Group Limited (“Auric”), a company formerly listed on the Mainboard of the SGX-ST. He was appointed a member of the board of commissioners of PT Lippo Karawaci Tbk, a company listed on the Indonesia Stock Exchange, on 18 April 2019. He retired as a non-independent and non-executive director of OUE Lippo Healthcare Limited, a company listed on Catalist Board of the SGX-ST, on 25 April 2019. Dr. Riady is a director of Lippo Capital Group Limited, Lippo Capital Holdings Company Limited, Lippo Capital Limited, First Tower Corporation (“First Tower”) and Skyscraper Realty Limited (“Skyscraper”) which, together with Lippo, have discloseable interests in the Company under the provisions of the Securities and Futures Ordinance. Dr. Riady is a graduate of the University of Southern California, United States of America and holds a Master of Business Administration from Golden Gate University, United States of America and an Honorary Degree of Doctor of Business Administration from Edinburgh Napier University, United Kingdom.

Luen wai Lee

Mr. Luen wai (John) Lee J.P., is Chief Executive Officer and Executive Director of Lippo China Resources Ltd. Mr. Lee is the Managing Director and Chief Executive Officer of Lippo. He is an executive director and the Chief Executive Officer of HKC, as well as an independent non-executive director of New World Development Company Limited and UMP Healthcare Holdings Limited, both are public listed companies in Hong Kong. He retired as a non-executive non-independent Chairman of HMC on 26 April 2019. He is a director of First Tower and Skyscraper. Mr. Lee is an authorised representative of the Company, Lippo and HKC. In addition, he holds directorships in certain subsidiaries of the Company, Lippo and HKC. Mr. Lee is a Fellow of The Institute of Chartered Accountants in England and Wales, the Association of Chartered Certified Accountants and the Hong Kong Institute of Certified Public Accountants. He was a partner of Price Waterhouse (now known as PricewaterhouseCoopers) in Hong Kong and has extensive experience in corporate finance and capital markets. Mr. Lee is an Honorary Fellow of the City University of Hong Kong, a Justice of Peace in Hong Kong and an awardee of the Bronze Bauhinia Star by the Government of the Hong Kong Special Administrative Region. Mr. Lee is active in public service. Over the years, he has served as a member or chairman of different government boards and committees in Hong Kong, including a member of the Hong Kong Hospital Authority and the Chairman of the Hospital Governing Committee of the Queen Elizabeth Hospital. Currently, he serves as the Chairman of the Hospital Governing Committee of Hong Kong Children’s Hospital, a member of the Public Service Commission and the Chairman of the Investment Committee of the Hospital Authority Provident Fund Scheme.

Siu Lung Lee

Mr. Siu Lung Lee is Executive Director of Lippo China Resources Limited. since 1st May, 2015. Mr. Lee has over 15 years of experience in mergers and acquisitions on technology companies. Mr. Lee joined Lippo Securities Limited (“LSL”), a former subsidiary of HKC, in 1997 and was the Head of Derivatives Department before he left LSL in late 1999. Mr. Lee was subsequently appointed as an assistant to the then Managing Director of the Company in early 2000 and left the Company in early 2009. He was a director of Systech Century Group from 2009 to 2014. In December 2014, Mr. Lee rejoined the Group and was appointed an Executive Vice President of business development. He also holds directorship in certain subsidiaries of the Company. Mr. Lee holds a Bachelor degree in Manufacturing Engineering with honours from Queen’s University, Belfast, United Kingdom and a Doctor degree in Engineering (major in Hierarchical Operations Management and Control for Automated Systems and Robotics) from The University of Hong Kong. He also holds a Master of Laws (major in International Economic Law) from The Chinese University of Hong Kong.

Yuen Fun Luk

Ms. Yuen Fun (Millie) Luk is Company Secretary of Lippo China Resources Ltd. She is also an authorised representative of the Company. Ms. Luk is a fellow member of both the Institute of Chartered Secretaries and Administrators and the Hong Kong Institute of Chartered Secretaries. She is also a member of Hong Kong Securities Institute. She has over 15 years' experience in the company secretarial field.

Nim Leung Chan

Mr. Nim Leung (Leon) Chan is Non-Executive Director of Lippo China Resources Ltd., He was appointed an independent non-executive Director of the Company in 1997 and was re-designated as a non-executive Director of the Company in September 2004. He is a practising lawyer and presently the principal partner of Messrs. Y.T. Chan & Co. He was admitted as a solicitor of the Supreme Court of Hong Kong in 1980 and was also admitted as a solicitor in England in 1984 and in Victoria, Australia in 1985. He was a member of the Solicitors Disciplinary Tribunal from May 1993 to April 2008. He is also a non-executive director of Lippo and HKC. Mr. Chan is a member of the Audit Committee, Remuneration Committee and Nomination Committee of each of the Company, Lippo and HKC.

Edwin Neo

Mr. Edwin Neo is Independent Non-Executive Director of Lippo China Resources Ltd., Since March 2002. He was admitted as a solicitor of the Supreme Court of Hong Kong in 1976 and of the Supreme Court of England and Wales in 1993. Mr. Neo is a practising lawyer and a notary public and is presently the senior partner of Hoosenally & Neo, Solicitors & Notaries. Mr. Neo holds a Bachelor of Laws degree with honours and Post-graduate Certificate in Laws from The University of Hong Kong. He is also an independent non-executive director of Lippo and HKC. Mr. Neo is also a member of the Remuneration Committee, Nomination Committee and Audit Committee of each of the Company, Lippo and HKC.

King Fai Tsui

Mr. King Fai Tsui is Independent Non-Executive Director of Lippo China Resources Ltd., Since September 2004. Mr. Tsui is an independent non-executive director of Vinda International Holdings Limited, China Aoyuan Group Limited (formerly known as China Aoyuan Property Group Limited) and Newton Resources Ltd, all are public listed companies in Hong Kong. He has over 40 years of extensive experience in accounting, finance and investment management, particularly in investments in mainland China. Mr. Tsui worked for two of the Big Four audit firms in the United States of America and Hong Kong and served in various public listed companies in Hong Kong in a senior capacity. He is a Fellow of the Hong Kong Institute of Certified Public Accountants, a member of the Chartered Accountants Australia and New Zealand and a member of the American Institute of Certified Public Accountants. He graduated from the University of Houston, Texas, the United States of America and holds a Master of Science in Accountancy and a Bachelor of Business Administration with first class honours. Mr. Tsui is an independent non-executive director of Lippo and HKC. He is the Chairman of the Audit Committee of HKC and a member of the Audit Committee of each of the Company and Lippo. He is also the Chairman of the Remuneration Committee and Nomination Committee of each of the Company, Lippo and HKC.

Ha Kuk Yung

Mr. Ha Kuk (Victor) Yung is Independent Non-Executive Director of Lippo China Resources Ltd., Since September 2004. Mr. Yung is a professional accountant with over 30 years of working experience in the financial and accounting fields, and served in management positions in various multinational companies in Asia. Mr. Yung holds a Master of Science Degree in Corporate Governance and Directorship from the Hong Kong Baptist University, and is a member of the Hong Kong Institute of Certified Public Accountants. He is also an independent non-executive director of Lippo and HKC. Mr. Yung is the Chairman of the Audit Committee of each of the Company and Lippo and a member of the Audit Committee of HKC. He is also a member of the Remuneration Committee and Nomination Committee of each of the Company, Lippo and HKC. Mr. Yung is an independent non-executive director of Travel Expert (Asia) Enterprises Limited, a public listed company in Hong Kong.

Basic Compensation

Name Fiscal Year Total

Tjondro Riady

36,604,000

Luen wai Lee

15,102,000

Siu Lung Lee

2,258,000

Yuen Fun Luk

--

Nim Leung Chan

826,000

Edwin Neo

--

King Fai Tsui

--

Ha Kuk Yung

--
As Of  31 Mar 2019